Smith & Nephew plc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and tra…
Medical - Devices
GB, Watford [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Smith & Nephew plc's gradings, price targets and earnings estimates.
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
Reported
Past Estimate Consensus
Future Estimate Consensus
FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
E | E | E | E | E | E | |||||||
2015 | 0.5600 | 0.812 | 4,617 | 4,618 | 501 | 708 | 1,188 | 983 | 749 | 492 | 2,471 | 2,503 |
2016 | 0.4600 | 0.817 | 4,634 | 4,691 | 410 | 713 | 1,119 | 999 | 628 | 500 | 2,641 | 2,543 |
2017 | 0.8800 | 0.876 | 4,669 | 4,782 | 784 | 765 | 1,266 | 1,018 | 801 | 509 | 2,366 | 2,592 |
2018 | 0.8800 | 0.955 | 4,765 | 4,912 | 767 | 833 | 1,396 | 1,046 | 934 | 523 | 2,360 | 2,663 |
2019 | 0.7600 | 1.012 | 4,904 | 5,119 | 663 | 883 | 1,294 | 1,090 | 863 | 545 | 2,497 | 2,775 |
2020 | 0.7100 | 0.629 | 5,138 | 4,614 | 600 | 549 | 1,326 | 982 | 815 | 491 | 2,693 | 2,501 |
2021 | 0.5500 | 0.827 | 4,560 | 5,218 | 448 | 721 | 904 | 1,111 | 295 | 556 | 2,562 | 2,829 |
2022 | 0.5900 | 0.777 | 5,212 | 5,199 | 524 | 678 | 1,172 | 1,107 | 593 | 554 | 2,720 | 2,819 |
2023 | 0.2500 | 0.822 | 5,215 | 5,546 | 223 | 717 | 943 | 1,181 | 450 | 591 | 2,880 | 3,006 |
2024 | - | 0.839 | - | 5,793 | - | 732 | - | 1,233 | - | 617 | - | 3,140 |
2025 | - | 0.993 | - | 6,088 | - | 866 | - | 1,296 | - | 649 | - | 3,300 |
2026 | - | 1.105 | - | 6,396 | - | 2.F11X/td> | - | 2.F111/td> | - | 2.F111 | - | 2.F111 |
2027 | - | 1.214 | - | 6,757 | - | 1.F12X/td> | - | 1.F121/td> | - | 1.F121 | - | 1.F121 |
2028 | - | 1.351 | - | 7,242 | - | 0.F13X/td> | - | 0.F131/td> | - | 0.F131 | - | 0.F131 |
Institutional Sentiment
Wall Street · Earnings · Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Overall Consensus
Grading Consensus
Click to each, to see the gradePrice Target Consensus
Nov. 6, 2024Price Then
$12.52
Price Target
$n/a
Price Now
$12.25